Thank you to all who helped make the Speaker Series a great success!
Speaker Series Videos
Election 2020 — What Does the Presidential Election Mean for Health Care Policy Going Forward? — 12/4/20
COVID-19 — Where Does the Nation Go from Here? — 11/20/20
COVID-19 Crisis – An Update from Massachusetts Leaders — 11/6/20
The 2020 Health Policy Speaker Series will take the place of MAHP’s annual conference this year. We look forward to seeing you at next year’s conference!
Thank you to our generous sponsors…
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Preti Strategies is an elite team of former lawmakers and experienced leaders in government relations, public affairs and communications. With offices in Massachusetts and New Hampshire, they have worked with clients to achieve goals nationwide.
Advisory Board helps health care leaders, including health plan executives, advance their organization’s strategic goals and navigate a rapidly changing environment through research-based insights, actionable strategies, and practical tools.
Agios Pharmaceuticals creates differentiated, small molecule medicines for patients in three focus areas – malignant hematology, solid tumors and rare genetic diseases – based on their unique expertise in cellular metabolism and adjacent areas of biology.
HealthEdge is an agile and innovative solutions company focused on providing next-generation, business-transforming technology products to the healthcare payor market.
HMS advances healthcare by helping healthcare organizations reduce costs and improve health outcomes.
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with 28 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders.
Novo Nordisk makes innovative medicines to help people with diabetes manage their disease. The company’s ultimate goal is to defeat diabetes through prevention, detection and better management, and empower people with diabetes to live longer, healthier lives.
MAHP 2020 Health Policy Speaker Series
Friday, November 6: COVID-19 Crisis – An Update from Massachusetts Leaders
9:00 a.m. – 9:30 a.m.
COVID-19 – Where Does Massachusetts Go from Here?
Marylou Sudders, MSW, ACSW, Secretary, Massachusetts Executive Office of Health & Human Services
9:30 a.m. – 10:00 a.m.
State of the State – A View from the Legislature
Robert A. DeLeo, Speaker, Massachusetts House of Representatives
Friday, November 20: COVID-19 — Where Does the Nation Go from Here?
9:00 a.m. – 10:00 a.m.
Dr. Ashish Jha, MD, Dean, Brown University School of Public Health
Friday, December 4: Election 2020 – What Does the Presidential Election Mean for Health Care Policy Going Forward?
9:00 a.m. – 10:00 a.m.
John McDonough, DrPH, MPA, Professor of Public Health Practice in the Department of Health Policy & Management, Harvard T.H. Chan School of Public Health
Avik Roy, President, Foundation for Research on Equal Opportunity & Policy Editor at Forbes
Moderator: Jim Braude, Host, Greater Boston, GBH Channel 2; Co-Host, Boston Public Radio, GBH 89.7FM